Literature DB >> 29255329

Ovulation, a sign of health.

Pilar Vigil1,2, Carolina Lyon1, Betsi Flores1, Hernán Rioseco1, Felipe Serrano1.   

Abstract

The concept of the ovarian continuum can be understood as a process that occurs during a woman's lifetime and begins during intrauterine life with fertilization. Women start their reproductive years with approximately five hundred thousand follicles containing oocytes, of which only around five hundred will be released during ovulation. Ovulation has been recognized as an event linked with reproduction; however, recent evidence supports the role of ovulation as a sign of health. The use of biomarkers that help women recognize ovulation enables them to identify their health status. This knowledge helps medical healthcare providers in the prevention, diagnosis, and treatment of different pathologies related with endocrine disorders, gynecological abnormalities, autoimmune, genetic, and neoplastic diseases, as well as pregnancy-related issues. The knowledge of the ovarian continuum and the use of biomarkers to recognize ovulation should be considered a powerful tool for women and medical professionals.
SUMMARY: The ovarian continuum is a process that occurs during a woman's lifetime. It begins during intrauterine life with fertilization and ends with menopause. This process can be greatly affected by different conditions such as changes in hormonal levels and illnesses. Therefore, understanding and promoting the knowledge and use of biomarkers of ovulation in women is a key aspect to consider when evaluating their health status. The knowledge and education about the ovarian continuum should be taken into account as a powerful tool for women and medical professionals.

Entities:  

Keywords:  Biomarkers; Ovarian continuum; Ovulation; Women’s health

Year:  2017        PMID: 29255329      PMCID: PMC5730019          DOI: 10.1080/00243639.2017.1394053

Source DB:  PubMed          Journal:  Linacre Q        ISSN: 0024-3639


  65 in total

1.  Hormonal monitoring of ovarian activity using the Ovarian Monitor, part I. Validation of home and laboratory results obtained during ovulatory cycles by comparison with radioimmunoassay.

Authors:  Leonard F Blackwell; James B Brown; Pilar Vigil; Barbara Gross; Saulat Sufi; Catherine d'Arcangues
Journal:  Steroids       Date:  2003-05       Impact factor: 2.668

2.  Quantitative morphological investigations of the follicular system in women; variations at different ages.

Authors:  E BLOCK
Journal:  Acta Anat (Basel)       Date:  1952

3.  Resistance to the satiety action of leptin following chronic central leptin infusion is associated with the development of leptin resistance in neuropeptide Y neurones.

Authors:  A Sahu
Journal:  J Neuroendocrinol       Date:  2002-10       Impact factor: 3.627

4.  Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area.

Authors:  C F Elias; C Aschkenasi; C Lee; J Kelly; R S Ahima; C Bjorbaek; J S Flier; C B Saper; J K Elmquist
Journal:  Neuron       Date:  1999-08       Impact factor: 17.173

5.  Disturbances of menstruation in hypothyroidism.

Authors:  G E Krassas; N Pontikides; T Kaltsas; P Papadopoulou; J Paunkovic; N Paunkovic; L H Duntas
Journal:  Clin Endocrinol (Oxf)       Date:  1999-05       Impact factor: 3.478

6.  Menstrual cycle pattern and fertility: a prospective follow-up study of pregnancy and early embryonal loss in 295 couples who were planning their first pregnancy.

Authors:  H A Kolstad; J P Bonde; N H Hjøllund; T K Jensen; T B Henriksen; E Ernst; A Giwercman; N E Skakkebaek; J Olsen
Journal:  Fertil Steril       Date:  1999-03       Impact factor: 7.329

Review 7.  Progesterone as a mediator of gonadotrophin action in the corpus luteum: beyond steroidogenesis.

Authors:  R L Stouffer
Journal:  Hum Reprod Update       Date:  2003 Mar-Apr       Impact factor: 15.610

8.  Morphological characterization of different human cervical mucus types using light and scanning electron microscopy.

Authors:  M Menárguez; L M Pastor; E Odeblad
Journal:  Hum Reprod       Date:  2003-09       Impact factor: 6.918

9.  Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years.

Authors:  M H A van Hooff; F J Voorhorst; M B H Kaptein; R A Hirasing; C Koppenaal; J Schoemaker
Journal:  Hum Reprod       Date:  2004-02       Impact factor: 6.918

10.  Does anovulation exist in eumenorrheic women?

Authors:  Christine E Malcolm; David C Cumming
Journal:  Obstet Gynecol       Date:  2003-08       Impact factor: 7.661

View more
  5 in total

Review 1.  Fertility Awareness-Based Methods for Women's Health and Family Planning.

Authors:  Marguerite Duane; Joseph B Stanford; Christina A Porucznik; Pilar Vigil
Journal:  Front Med (Lausanne)       Date:  2022-05-24

Review 2.  Chronic Stress and Ovulatory Dysfunction: Implications in Times of COVID-19.

Authors:  Pilar Vigil; Jaime Meléndez; Hugo Soto; Grace Petkovic; Yanara A Bernal; Santiago Molina
Journal:  Front Glob Womens Health       Date:  2022-05-23

3.  Systematic Review of Ovarian Activity and Potential for Embryo Formation and Loss during the Use of Hormonal Contraception.

Authors:  Donna Harrison; Cara Buskmiller; Monique Chireau; Lester A Ruppersberger; Patrick P Yeung
Journal:  Linacre Q       Date:  2019-01-03

Review 4.  Steroid Hormones and Their Action in Women's Brains: The Importance of Hormonal Balance.

Authors:  Juan Pablo Del Río; María I Alliende; Natalia Molina; Felipe G Serrano; Santiago Molina; Pilar Vigil
Journal:  Front Public Health       Date:  2018-05-23

5.  Experiences of menstrual inequity and menstrual health among women and people who menstruate in the Barcelona area (Spain): a qualitative study.

Authors:  Anna Sofie Holst; Constanza Jacques-Aviñó; Anna Berenguera; Diana Pinzón-Sanabria; Carme Valls-Llobet; Jordina Munrós-Feliu; Cristina Martínez-Bueno; Tomàs López-Jiménez; Mª Mercedes Vicente-Hernández; Laura Medina-Perucha
Journal:  Reprod Health       Date:  2022-02-19       Impact factor: 3.223

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.